Bracco Company Profile

✉ Email this page to a colleague

BRACCO has forty approved drugs.

There are three US patents protecting BRACCO drugs.

There are thirty-seven patent family members on BRACCO drugs in twelve countries and seventy-four supplementary protection certificates in eight countries.

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Bracco	RENO-DIP	diatrizoate meglumine	INJECTABLE;INJECTION	010040-012	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Bracco	CHOLOGRAFIN SODIUM	iodipamide sodium	INJECTABLE;INJECTION	009321-001	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Bracco	CHLORMERODRIN HG 197	chlormerodrin hg-197	INJECTABLE;INJECTION	017269-001	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Bracco	VARIBAR THIN LIQUID	barium sulfate	FOR SUSPENSION;ORAL	208036-004	Apr 30, 2019		RX	Yes	Yes		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Bracco	PROHANCE	gadoteridol	INJECTABLE;INJECTION	020131-001	Nov 16, 1992	4,885,363	⤷ Try a Trial
Bracco	KINEVAC	sincalide	INJECTABLE;INJECTION	017697-001	Approved Prior to Jan 1, 1982	6,803,046	⤷ Try a Trial
Bracco	CARDIOTEC	technetium tc-99m teboroxime kit	INJECTABLE;INJECTION	019928-001	Dec 19, 1990	6,056,941	⤷ Try a Trial
Bracco	CARDIOGEN-82	rubidium chloride rb-82	INJECTABLE;INJECTION	019414-001	Dec 29, 1989	4,562,829	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Estimated Expiration
South Korea	102624471	⤷ Try a Trial
World Intellectual Property Organization (WIPO)	2020008031	⤷ Try a Trial
South Africa	202108096	⤷ Try a Trial
European Patent Office	3969065	⤷ Try a Trial
>Country	>Patent Number	>Estimated Expiration

Subscribe to access the full database, or Try a Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
2822954	1890030-8	Sweden	⤷ Try a Trial	PRODUCT NAME: BICTEGRAVIR OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, IN PARTICULAR BICTEGRAVIR SODIUM; REG. NO/DATE: EU/1/18/1289 20180625
2203431	92666	Luxembourg	⤷ Try a Trial	PRODUCT NAME: DASABUVIR OU UN SEL QUI EN DERIVE, Y COMPRIS DASABUVIR SODIUMMONOHYDRATE. FIRST REGISTRATION: 20150119
0230893	SPC/GB97/081	United Kingdom	⤷ Try a Trial	PRODUCT NAME: GADOBENATE DIMEGLUMINE; REGISTERED: UK 06099/0006 19970722
2203431	15C0013	France	⤷ Try a Trial	PRODUCT NAME: DASABUVIR OU UN SEL DE CELUI-CI, NOTAMMENT LE SEL DE SODIUM; REGISTRATION NO/DATE: EU/1/14/983 20150119
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.